Terug
Dagbereik
€ 2,33
€ 2,78
52-Weeksbereik
€ 1,62
€ 3,50
Volume
300
50D / 200D Gem.
€ 2,62
/
€ 2,73
Vorige Slotkoers
€ 2,44
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,3 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | 6,0 | 3,7 |
| Net Margin % | 6,7 | 3,8 |
| Rev Growth 5Y % | 7,9 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 1,72
€ 1,55 – € 1,86
|
46 B | 1 |
| FY2026 |
€ 1,62
€ 1,46 – € 1,75
|
44 B | 1 |
Belangrijkste Punten
Revenue grew 7,89% annually over 5 years — modest growth
Earnings grew 16,08% over the past year
Generating 66,79M in free cash flow
P/E of 2,33 — trading at a low valuation
PEG of 0,75 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,69%
Groei
Revenue Growth (5Y)
7,89%
Revenue (1Y)-0,80%
Earnings (1Y)16,08%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
5,96%
ROIC4,03%
Net Margin6,74%
Op. Margin10,34%
Veiligheid
Debt / Equity
0,67
Current Ratio0,92
Interest Coverage2,96
Waardering
P/E Ratio
2,33
P/B Ratio0,14
EV/EBITDA5,80
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,80% | Revenue Growth (3Y) | -3,34% |
| Earnings Growth (1Y) | 16,08% | Earnings Growth (3Y) | -13,84% |
| Revenue Growth (5Y) | 7,89% | Earnings Growth (5Y) | -6,75% |
| Profitability | |||
| Revenue (TTM) | 41,07B | Net Income (TTM) | 2,77B |
| ROE | 5,96% | ROA | 2,36% |
| Gross Margin | 47,97% | Operating Margin | 10,34% |
| Net Margin | 6,74% | Free Cash Flow (TTM) | 66,79M |
| ROIC | 4,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,67 | Current Ratio | 0,92 |
| Interest Coverage | 2,96 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 2,33 | P/B Ratio | 0,14 |
| P/S Ratio | 0,16 | PEG Ratio | 0,75 |
| EV/EBITDA | 5,80 | Dividend Yield | 0,06% |
| Market Cap | 6,46B | Enterprise Value | 24,63B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 41,07B | 41,40B | 43,95B | 39,01B | 30,31B |
| Net Income | 2,77B | 2,39B | 3,73B | 4,73B | 3,66B |
| EPS (Diluted) | 1,04 | 0,89 | 1,43 | 1,85 | 1,43 |
| Gross Profit | 19,70B | 19,80B | 20,78B | 18,78B | 16,88B |
| Operating Income | 4,25B | 3,31B | 8,30B | 6,31B | 4,72B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 117,46B | 113,47B | 107,16B | 93,29B | 83,69B |
| Total Liabilities | 57,53B | 56,85B | 53,05B | 44,92B | 37,70B |
| Shareholders' Equity | 47,26B | 45,68B | 44,58B | 39,19B | 37,00B |
| Total Debt | 31,70B | 30,28B | 30,25B | 24,25B | 24,01B |
| Cash & Equivalents | 13,52B | 13,69B | 16,24B | 10,31B | 9,96B |
| Current Assets | 34,49B | 33,79B | 35,28B | 30,42B | 25,08B |
| Current Liabilities | 37,45B | 33,76B | 33,30B | 29,31B | 24,87B |